Inter-tissue expression patterns of the key metabolic biomarker PGC-1α in severely obese individuals: Implication in obesity-induced disease

Foussas, 2016, Obesity and acute coronary syndromes, Hellenic J Cardiol, 57, 63, 10.1016/S1109-9666(16)30023-9 Foussas, 2015, Acute coronary syndromes and comorbidities, Hellenic J Cardiol, 56, 351 Synetos, 2017, Atherosclerosis and inflammation. Clinical Aspects of a Modern Tale, Hellenic J Cardiol, 58, 122, 10.1016/j.hjc.2017.05.013 Kaur, 2014, A Comprehensive review on metabolic syndrome, Cardiol Res Pract, 2014, 943162, 10.1155/2014/943162 Federation:, ID. The Idf consensus worldwide definition of the metabolic syndrome.; Available from: http://www.idf.org/metabolic-syndrome. Skliros, 2016, Treatment of diabetes: crossing to the Other Side, Hellenic J Cardiol, 57, 304, 10.1016/j.hjc.2016.07.002 Tentolouris, 2017, Diabetes mellitus doubles the risk of type 2 cardiorenal syndrome: results from the Nhanes trial, Hellenic J Cardiol, 58, 348, 10.1016/j.hjc.2017.11.013 Lin, 2005, Metabolic control through the Pgc-1 family of transcription coactivators, Cell Metabol, 1, 361, 10.1016/j.cmet.2005.05.004 Finck, 2006, Pgc-1 coactivators: inducible regulators of energy metabolism in health and disease, J Clin Invest, 116, 615, 10.1172/JCI27794 Puigserver, 1998, A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis, Cell, 92, 829, 10.1016/S0092-8674(00)81410-5 Vega, 2000, The coactivator Pgc-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes, Mol Cell Biol, 20, 1868, 10.1128/MCB.20.5.1868-1876.2000 Barbera, 2001, Peroxisome proliferator-activated receptor alpha activates transcription of the brown fat uncoupling protein-1 gene. A link between regulation of the thermogenic and lipid oxidation pathways in the brown fat cell, J Biol Chem, 276, 1486, 10.1074/jbc.M006246200 Uldry, 2006, Complementary action of the Pgc-1 coactivators in mitochondrial biogenesis and brown fat differentiation, Cell Metabol, 3, 333, 10.1016/j.cmet.2006.04.002 Sano, 2005, Energizer: Pgc-1 Alpha Keeps the Heart Going, Cell Metabol, 1, 216, 10.1016/j.cmet.2005.03.009 Arany, 2005, Transcriptional coactivator Pgc-1 alpha controls the energy state and contractile function of cardiac muscle, Cell Metabol, 1, 259, 10.1016/j.cmet.2005.03.002 Ikeda, 2006, Muscle Type-specific response of Pgc-1 alpha and oxidative enzymes during voluntary wheel running in mouse skeletal muscle, Acta Physiol (Oxf)., 188, 217, 10.1111/j.1748-1716.2006.01623.x Tritos, 2003, Characterization of the peroxisome proliferator activated receptor coactivator 1 alpha (Pgc 1alpha) expression in the murine brain, Brain Res, 961, 255, 10.1016/S0006-8993(02)03961-6 Portilla, 2003, Energy metabolism and cytotoxicity, Semin Nephrol, 23, 432, 10.1016/S0270-9295(03)00088-3 Pirinen, 2007, Enhanced polyamine catabolism alters homeostatic control of white adipose tissue mass, energy expenditure, and glucose metabolism, Mol Cell Biol, 27, 4953, 10.1128/MCB.02034-06 Pilegaard, 2003, Exercise induces transient transcriptional activation of the pgc-1alpha gene in human skeletal muscle, J Physiol, 546, 851, 10.1113/jphysiol.2002.034850 Baar, 2002, Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator Pgc-1, FASEB J, 16, 1879, 10.1096/fj.02-0367com Herzig, 2001, Creb regulates hepatic gluconeogenesis through the coactivator Pgc-1, Nature, 413, 179, 10.1038/35093131 Puigserver, 2005, Tissue-specific regulation of metabolic pathways through the transcriptional coactivator Pgc1-alpha, Int J Obes (Lond), 29, S5, 10.1038/sj.ijo.0802905 Tanner, 2002, Muscle fiber type is associated with obesity and weight loss, Am J Physiol Endocrinol Metab, 282, E1191, 10.1152/ajpendo.00416.2001 Chan, 2014, The many roles of pgc-1alpha in muscle--recent developments, Metabolism, 63, 441, 10.1016/j.metabol.2014.01.006 Liang, 2006, Pgc-1alpha: a key regulator of energy metabolism, Adv Physiol Educ, 30, 145, 10.1152/advan.00052.2006 Wu, 2016, Pgc-1alpha, glucose metabolism and type 2 diabetes mellitus, J Endocrinol, 229, R99, 10.1530/JOE-16-0021 Ek, 2001, Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (Pgc-1) and relationships of identified amino acid polymorphisms to type ii diabetes mellitus, Diabetologia, 44, 2220, 10.1007/s001250100032 Hara, 2002, A genetic variation in the Pgc-1 gene could confer insulin resistance and susceptibility to type Ii diabetes, Diabetologia, 45, 740, 10.1007/s00125-002-0803-z Villegas, 2014, Genetic Variation in the peroxisome proliferator-activated receptor (Ppar) and peroxisome proliferator-activated receptor gamma co-activator 1 (Pgc1) gene families and type 2 diabetes, Ann Hum Genet, 78, 23, 10.1111/ahg.12044 Mootha, 2003, Pgc-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat Genet, 34, 267, 10.1038/ng1180 Bellafante, 2013, Hepatic-specific activation of peroxisome proliferator-activated receptor gamma coactivator-1beta protects against steatohepatitis, Hepatology, 57, 1343, 10.1002/hep.26222 Kogelman, 2016, Inter-tissue gene co-expression networks between metabolically healthy and unhealthy obese individuals, PLoS One, 11, 10.1371/journal.pone.0167519 Canto, 2009, Pgc-1alpha, Sirt1 and Ampk, an energy sensing network that controls energy expenditure, Curr Opin Lipidol, 20, 98, 10.1097/MOL.0b013e328328d0a4 Hazlehurst, 2016, Non-alcoholic fatty liver disease and diabetes, Metabolism, 65, 1096, 10.1016/j.metabol.2016.01.001 Aharoni-Simon, 2011, Fatty liver is associated with impaired activity of ppargamma-coactivator 1alpha (Pgc1alpha) and mitochondrial biogenesis in mice, Lab Invest, 91, 1018, 10.1038/labinvest.2011.55 Sanyal, 2002, Aga Technical review on nonalcoholic fatty liver disease, Gastroenterology, 123, 1705, 10.1053/gast.2002.36572 Mensink, 2007, Improved skeletal muscle oxidative enzyme activity and restoration of Pgc-1 alpha and Ppar Beta/Delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus, Int J Obes (Lond), 31, 1302, 10.1038/sj.ijo.0803567 Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of Pgc1 and Nrf1, Proc Natl Acad Sci U S A, 100, 8466, 10.1073/pnas.1032913100 Hammarstedt, 2003, Reduced expression of Pgc-1 and insulin-signaling molecules in adipose tissue is associated with insulin resistance, Biochem Biophys Res Commun, 301, 578, 10.1016/S0006-291X(03)00014-7 Semple, 2004, Expression of the thermogenic nuclear hormone receptor coactivator Pgc-1alpha Is reduced in the adipose tissue of morbidly obese subjects, Int J Obes Relat Metab Disord, 28, 176, 10.1038/sj.ijo.0802482 Koo, 2004, Pgc-1 promotes insulin resistance in liver through Ppar-alpha-dependent induction of Trb-3, Nat Med, 10, 530, 10.1038/nm1044 Biddinger, 2008, Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis, Cell Metabol, 7, 125, 10.1016/j.cmet.2007.11.013 Yoon, 2003, Suppression of beta cell energy metabolism and insulin release by Pgc-1alpha, Dev Cell, 5, 73, 10.1016/S1534-5807(03)00170-9 Besse-Patin, 2017, Estrogen signals through peroxisome proliferator-activated receptor-gamma coactivator 1alpha to reduce oxidative damage associated with diet-induced fatty liver disease, Gastroenterology, 152, 243, 10.1053/j.gastro.2016.09.017 Turcotte, 2008, Skeletal muscle insulin resistance: roles of fatty acid metabolism and exercise, Phys Ther, 88, 1279, 10.2522/ptj.20080018 Rui, 2014, Energy metabolism in the liver, Comp Physiol, 4, 177, 10.1002/cphy.c130024 Pan, 1997, Skeletal muscle triglyceride levels are inversely related to insulin action, Diabetes, 46, 983, 10.2337/diab.46.6.983 Yang, 2017, Switching harmful visceral fat to beneficial energy combustion improves metabolic dysfunctions, JCI Insight, 2, 10.1172/jci.insight.89044 Chasapi, 2017 Filippidis, 2011, Compliance with a Healthy lifestyle in a representative sample of the greek population: preliminary results of the hellas health I study, Publ Health, 125, 436, 10.1016/j.puhe.2011.03.009 Kapantais, 2006, First national epidemiological survey on the prevalence of obesity and abdominal fat distribution in greek adults, Ann Nutr Metab, 50, 330, 10.1159/000094296 Khan, 2015, Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance, Int J Obes (Lond), 39, 1607, 10.1038/ijo.2015.104 Addison, 2014, Intermuscular fat: a review of the consequences and causes, Internet J Endocrinol, 2014, 309570 Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701 Roche, 2010, Extensive mononuclear infiltration and myogenesis characterize recovery of dysferlin-null skeletal muscle from contraction-induced injuries, Am J Physiol Cell Physiol, 298, C298, 10.1152/ajpcell.00122.2009 Mackey, 2011, Sequenced response of extracellular matrix deadhesion and fibrotic regulators after muscle damage is involved in protection against future injury in human skeletal muscle, FASEB J, 25, 1943, 10.1096/fj.10-176487 Wanschitz, 2013, Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositis, Neuromuscul Disord, 23, 75, 10.1016/j.nmd.2012.09.003 Reue, 2017, Sex differences in obesity: x chromosome dosage as a risk factor for increased food intake, adiposity and co-morbidities, Physiol Behav, 176, 174, 10.1016/j.physbeh.2017.02.040 Jackson, 2002, The effect of sex, age and race on estimating percentage body fat from body mass index: the heritage family study, Int J Obes Relat Metab Disord, 26, 789, 10.1038/sj.ijo.0802006 Goodpaster, 2005, Obesity, regional body fat distribution, and the metabolic syndrome in older men and women, Arch Intern Med, 165, 777, 10.1001/archinte.165.7.777 Demerath, 2007, Anatomical patterning of visceral adipose tissue: race, sex, and age variation, Obesity (Silver Spring), 15, 2984, 10.1038/oby.2007.356 Yim, 2008, Femoral-gluteal subcutaneous and intermuscular adipose tissues have independent and opposing relationships with Cvd risk, J Appl Physiol (1985), 104, 700, 10.1152/japplphysiol.01035.2007 Camhi, 2011, The relationship of waist circumference and bmi to visceral, subcutaneous, and total body fat: sex and race differences, Obesity (Silver Spring), 19, 402, 10.1038/oby.2010.248 Beasley, 2009, Inflammation and race and gender differences in computerized tomography-measured adipose depots, Obesity (Silver Spring), 17, 1062, 10.1038/oby.2008.627 Bryzgalova, 2008, Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice, Am J Physiol Endocrinol Metab, 295, E904, 10.1152/ajpendo.90248.2008 Lafontan, 2005, Fat cells: afferent and efferent messages define new approaches to treat obesity, Annu Rev Pharmacol Toxicol, 45, 119, 10.1146/annurev.pharmtox.45.120403.095843 Silver, 1993, Effect of aging on body fat, J Am Geriatr Soc, 41, 211, 10.1111/j.1532-5415.1993.tb06693.x Jung, 2015, Age-related increase in ldl-cholesterol is associated with enhanced oxidative stress and disturbed sphingolipid metabolism, Metabolomics, 11, 40, 10.1007/s11306-014-0669-3 Choi, 2015, Sphingolipids in high fat diet and obesity-related diseases, Mediat Inflamm, 2015, 520618, 10.1155/2015/520618 Estall, 2009, Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression, Diabetes, 58, 1499, 10.2337/db08-1571 Chen, 2013, Gly482ser mutation impairs the effects of peroxisome proliferator-activated receptor gamma coactivator-1alpha on decreasing fat deposition and stimulating phosphoenolpyruvate carboxykinase expression in hepatocytes, Nutr Res, 33, 332, 10.1016/j.nutres.2013.02.003 Morris, 2012, Pgc-1alpha overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion, Am J Physiol Gastrointest Liver Physiol, 303, G979, 10.1152/ajpgi.00169.2012 Nassir, 2014, Role of mitochondria in nonalcoholic fatty liver disease, Int J Mol Sci, 15, 8713, 10.3390/ijms15058713 Short, 2005, Decline in skeletal muscle mitochondrial function with aging in humans, Proc Natl Acad Sci U S A, 102, 5618, 10.1073/pnas.0501559102 Petersen, 2003, Mitochondrial dysfunction in the elderly: possible role in insulin resistance, Science, 300, 1140, 10.1126/science.1082889 van Vliet-Ostaptchouk, 2014, The prevalence of metabolic syndrome and metabolically healthy obesity in europe: a collaborative analysis of ten large cohort studies, BMC Endocr Disord, 14, 9, 10.1186/1472-6823-14-9 Ruschke, 2010, Gene expression of Ppargamma and Pgc-1alpha in human omental and subcutaneous adipose tissues is related to insulin resistance markers and mediates beneficial effects of physical training, Eur J Endocrinol, 162, 515, 10.1530/EJE-09-0767 Yim, 2007, Intermuscular adipose tissue rivals visceral adipose tissue in independent associations with cardiovascular risk, Int J Obes (Lond), 31, 1400, 10.1038/sj.ijo.0803621 Durheim, 2008, Relationships between exercise-induced reductions in thigh intermuscular adipose tissue, changes in lipoprotein particle size, and visceral adiposity, Am J Physiol Endocrinol Metab, 295, E407, 10.1152/ajpendo.90397.2008 Machado, 2012, Liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance, PLoS One, 7, 10.1371/journal.pone.0031738 Anderson, 2008, Dynamic regulation of Pgc-1alpha localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response, Aging Cell, 7, 101, 10.1111/j.1474-9726.2007.00357.x Aquilano, 2013, Extranuclear localization of Sirt1 and Pgc-1alpha: an insight into possible roles in diseases associated with mitochondrial dysfunction, Curr Mol Med, 13, 140, 10.2174/156652413804486241 Little, 2010, Acute endurance exercise increases the nuclear abundance of pgc-1alpha in trained human skeletal muscle, Am J Physiol Regul Integr Comp Physiol, 298, R912, 10.1152/ajpregu.00409.2009 Aquilano, 2010, Peroxisome proliferator-activated receptor gamma co-activator 1alpha (Pgc-1alpha) and Sirtuin 1 (Sirt1) reside in mitochondria: possible direct function in mitochondrial biogenesis, J Biol Chem, 285, 21590, 10.1074/jbc.M109.070169 Ma, 2012, Mitochondrial dysfunction and beta-cell failure in type 2 diabetes mellitus, Exp Diabetes Res, 2012, 703538, 10.1155/2012/703538 Zorzano, 2010, Alterations in the mitochondrial regulatory pathways constituted by the nuclear co-factors Pgc-1alpha or Pgc-1beta and mitofusin 2 in skeletal muscle in type 2 diabetes, Biochim Biophys Acta, 1797, 1028, 10.1016/j.bbabio.2010.02.017 Handschin, 2007, Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in pgc-1alpha muscle-specific knock-out animals, J Biol Chem, 282, 30014, 10.1074/jbc.M704817200 Joseph, 2012, Mitochondrial dysregulation in the pathogenesis of diabetes: potential for mitochondrial biogenesis-mediated interventions, Exp Diabetes Res, 2012, 642038, 10.1155/2012/642038 Kleiner, 2012, Development of insulin resistance in mice lacking Pgc-1alpha in adipose tissues, Proc Natl Acad Sci U S A, 109, 9635, 10.1073/pnas.1207287109 Lagouge, 2006, Resveratrol improves mitochondrial function and protects against metabolic disease by activating sirt1 and Pgc-1alpha, Cell, 127, 1109, 10.1016/j.cell.2006.11.013 Tan, 2008, Resveratrol exerts pharmacological preconditioning by activating Pgc-1alpha, Med Hypotheses, 71, 664, 10.1016/j.mehy.2008.06.031 Wajchenberg, 2000, Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome, Endocr Rev, 21, 697, 10.1210/edrv.21.6.0415 Misra, 2003, Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots, Nutrition, 19, 457, 10.1016/S0899-9007(02)01003-1 Bjorntorp, 2000, Metabolic difference between visceral fat and subcutaneous abdominal fat, Diabetes Metab, 26, 10 Ibrahim, 2010, Subcutaneous and Visceral adipose tissue: structural and functional differences, Obes Rev, 11, 11, 10.1111/j.1467-789X.2009.00623.x Wolfs, 2010, Co-expressed immune and metabolic genes in visceral and subcutaneous adipose tissue from severely obese individuals are associated with plasma Hdl and glucose levels: a microarray study, BMC Med Genom, 3, 34, 10.1186/1755-8794-3-34 Oh, 2016, Metabolic adaptation in obesity and type ii diabetes: myokines, adipokines and hepatokines, Int J Mol Sci, 18, 10.3390/ijms18010008 Furrer, 2017, Paracrine cross-talk between skeletal muscle and macrophages in exercise by Pgc-1alpha-Controlled Bnp, Sci Rep, 7, 40789, 10.1038/srep40789 Hilton, 2008, Excessive adipose tissue infiltration in skeletal muscle in individuals with obesity, diabetes mellitus, and peripheral neuropathy: association with performance and function, Phys Ther, 88, 1336, 10.2522/ptj.20080079 Gallagher, 2005, Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue, Am J Clin Nutr, 81, 903, 10.1093/ajcn/81.4.903 Bostrom, 2012, A Pgc1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis, Nature, 481, 463, 10.1038/nature10777 Lumeng, 2013, Innate immune activation in obesity, Mol Aspect Med, 34, 12, 10.1016/j.mam.2012.10.002 Shu, 2012, The immune system's involvement in obesity-driven type 2 diabetes, Semin Immunol, 24, 436, 10.1016/j.smim.2012.12.001 Wellen, 2005, Inflammation, stress, and diabetes, J Clin Invest, 115, 1111, 10.1172/JCI25102 Osborn, 2012, The cellular and signaling networks linking the immune system and metabolism in disease, Nat Med, 18, 363, 10.1038/nm.2627 Samaan, 2011, The macrophage at the intersection of immunity and metabolism in obesity, Diabetol Metab Syndrome, 3, 29, 10.1186/1758-5996-3-29 McNelis, 2014, Macrophages, immunity, and metabolic disease, Immunity, 41, 36, 10.1016/j.immuni.2014.05.010 Thul, 2017, A Subcellular map of the human proteome, Science, 356, 10.1126/science.aal3321 Maruyama, 2016, Palmitate-induced regulation of ppargamma via Pgc1alpha: a mechanism for lipid accumulation in the liver in nonalcoholic fatty liver disease, Int J Med Sci, 13, 169, 10.7150/ijms.13581 Norheim, 2014, The effects of acute and chronic exercise on Pgc-1alpha, irisin and browning of subcutaneous adipose tissue in humans, Febs j, 281, 739, 10.1111/febs.12619 Gastaldi, 2007, Upregulation of peroxisome proliferator-activated receptor gamma coactivator gene (Pgc1a) during weight loss is related to insulin sensitivity but not to energy expenditure, Diabetologia, 50, 2348, 10.1007/s00125-007-0782-1